This is a GSBR-1290 news story, published by Yahoo Finance, that relates primarily to Structure Therapeutic's news.
For more GSBR-1290 news, you can click here:
more GSBR-1290 newsFor more Structure Therapeutic's news, you can click here:
more Structure Therapeutic's newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
healthcare stocks. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Viking Therapeutics stock news, clinical catalysts news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
new weight loss drugsThe Motley Fool
•78% Informative
Viking Therapeutics has a number of data readouts coming up that will almost certainly lead to major movements in its share price.
The most impactful events will be when it reports data from its obesity-related clinical trials, both of which are testing formulations of its candidate VK2735.
Structure Therapeutic's candidate, GSBR-1290 , is intended to help with weight loss, and its phase 2b trials are anticipated to begin in the fourth quarter .
The phase 2a data were not necessarily a home run on that basis due to only gathering 12 weeks' worth of information.
So, appreciate the additional risk here before committing to buying the stock.
Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 722,626 !.
VR Score
75
Informative language
73
Neutral language
21
Article tone
informal
Language
English
Language complexity
45
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Source diversity
2
Affiliate links
no affiliate links